NCT04567589View on ClinicalTrials.gov

A Study to Evaluate Awareness and Knowledge of the Fibristal Additional Risk Minimization Measures Among Healthcare Professionals in Canada

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

September 30, 2020

Primary Completion Date

February 28, 2021

Study Completion Date

February 28, 2021

Conditions
Uterine Fibroids
Trial Locations (1)

92622

Clinical Trials Registry Team, Irvine

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY